266 In the index

Topiramate TOPI

An FDA-approved medication for seizures and migraine prevention, also combined with phentermine (Qsymia) for weight loss. Human studies support all three uses, though 'brain fog' and, rarely, kidney stones are recognized risks.

Also known as Topamax, Qsymia component

Effects Lose fat

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₁₂H₂₁NO₈S

Drag to rotate · scroll to zoom

Chemistry

Formula: C12H21NO8S
Molar mass: 339.36
CAS: 97240-79-4
PubChem CID: 5284627

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 25-200 mg/day, titrated

Reported range 25-400 mg/day depending on indication

Route Oral

Frequency 1-2 times daily

Duration Chronic/ongoing (as prescribed)

FDA-approved anticonvulsant (Topamax) for seizures and migraine prevention, also combined with phentermine (Qsymia) for weight loss; associated with cognitive side effects ('brain fog') and, rarely, kidney stones.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.